1.
Chinese Journal of Endocrinology and Metabolism
; (12)1985.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-676346
RESUMO
The change in plasma ghrelin level after 4-and 12-week adjunctive therapy of rosiglitazones in type 2 diabetic patients inadequately controlled by sulphonylurea alone was observed and the relation between ghrelin and insulin resistance was analysed.The results showed that rosiglitazones significantly increased circulating ghrelin level and obviously decreased insulin resistance index after therapy for 4 and 12 weeks in type 2 diabetic patients.